Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 1.4% and the Health Care Select Sector SPDR Fund (XLV) up 1.3%.
The iShares Biotechnology ETF (IBB) added 1.3%.
In corporate news, AstraZeneca (AZN) on Monday agreed to buy Belgian biotech company EsoBiotec in a deal worth up to $1 billion as it looks to boost its cell therapies portfolio. AstraZeneca shares were 0.1% higher.
Hyperfine (HYPR) shares surged 35% after the company said Monday it is collaborating with Nvidia (NVDA) to enhance its portable imaging technology.
Fortress Biotech (FBIO) shares popped 4.8%. The company and Partex said Monday that they're collaborating to identify and evaluate biopharmaceutical compounds using AI for potential acquisition or licensing by Fortress.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。